MFDS
- Marketing authorisation holder: INTRABIO
- Status: likely_approved
🇰🇷 Aqneursa in South Korea
Aqneursa (LEVACETYLLEUCINE) regulatory status in South Korea.
Marketing authorisation
Aqneursa in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Metabolic approved in South Korea
Frequently asked questions
Is Aqneursa approved in South Korea?
Yes. MFDS has authorised it.
Who is the marketing authorisation holder for Aqneursa in South Korea?
INTRABIO holds the South Korean marketing authorisation.